FIELD: medicine.
SUBSTANCE: application of the oxidised ATF form (o-ATF) as the antiangiogenic pharmacological agent, a therapeutic preparation for treatment of the tumours, including o-ATF with antitumoral substance and a therapeutic preparation for treatment of the atherosclerotic processes, containing o-ATF with antiatherosclerotic substances is offered. The agent is applicable for treatment of diseases, in whose beginning or advance the angiogenesis, such as diseases of eyes, atherosclerotic processes or tumours is involved.
EFFECT: maintenance of suppression of a proliferation of endothelial cells, or anti-angiogenic effect even in the presence of the endothelial factor of growth of vessels.
6 cl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BENZOQUINONE E3330 DERIVATIVE IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR TREATING CANCER AND ANGIOGENESIS | 2008 |
|
RU2510270C2 |
| INHIBITORS OF HISTONDEACETYLASE FOR TREATMENT OF OPHTHALMOLOGIC NEOVASCULAR DISTURBANCES AND DISEASES | 2003 |
|
RU2352337C2 |
| METHODS FOR TREATMENT OF TUMORS AND METASTASIS USING COMBINATION OF ANTI-ANGIOGENIC THERAPY AND IMMUNOTHERAPY | 2000 |
|
RU2236251C2 |
| COMBINED THERAPY BY USING ANTIANGIOGENIC AGENTS AND TNF-ALPHA | 2002 |
|
RU2316337C2 |
| ANGIOGENESIS INHIBITOR, ANTI-ANGIOGENIC PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT OF MALIGNANT NEOPLASM | 2005 |
|
RU2287341C1 |
| ANTIANGIOGENIC MEDICINAL AGENT AND METHOD OF ITS PRODUCTION | 2009 |
|
RU2404783C1 |
| METHOD FOR REDUCING MULTI-DRUG RESISTANCE WITH USING INOSITOL TRIPYROPHOSPHATE | 2010 |
|
RU2563127C2 |
| TREATING CANCER WITH COMBINATION OF RADIATION THERAPY, CERIUM OXIDE NANOPARTICLES AND CHEMOTHERAPEUTIC AGENT | 2015 |
|
RU2704811C2 |
| ANTIANGIOGENIC DRUG | 2016 |
|
RU2634253C1 |
| CANCER MEDICAL TREATMENT | 2005 |
|
RU2325906C2 |
